This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Hypothesis: Cytokine blockade with a human TNF-a monoclonal antibody (Adalimumab) is safe in the treatment of, and can improve the signs and symptoms of, inflammatory osteoarthritis (OA) of the hands. This will be a Phase II open-label pilot study of 12 patients with active erosive OA receiving Adalimumab 40 mg every other week for twelve weeks. Prior to study enrollment, each patient identified will have a clinical evaluation including medical history, physical examination, laboratory studies, vital signs (blood pressure, pulse, respiration, and oral temperature), PPD skin test, and a detailed list of concurrent medications. Results of laboratory tests required for eligibility will be reviewed and approved by a physician with inclusion/exclusion criteria met before patient receives study drug. Investigational drug will be supplied by Abbott Laboratories. The study drug will be provided as an injection solution in 1-mL pre-filled syringes containing 40 mg Adalimumab/0.8 mL (50 mg/mL concentration). Endpoints: The primary endpoint is the safety of treatment with Adalimumab in subjects with inflammatory OA following SC injections of 40 mg Adalimumab every other week for 12 weeks. To investigate the clinical efficacy of treatment with Adalimumab, co-primary endpoints will be observed: ACR20 at Week 12 and improvement in joint severity (inflammation and tenderness) at Week 12. The ACR 20 is defined by at least a 20% improvement from baseline in the number of tender and swollen joints and at least a 20% improvement in three of the five following domains: pain [based on visual analogue scale (VAS)], patient global assessment (PTGA), physician global assessment (MDGA), erythrocyte sedimentation rate, and Health Assessment Questionnaire disability index (HAQ-DI).

National Institute of Health (NIH)
National Center for Research Resources (NCRR)
General Clinical Research Centers Program (M01)
Project #
Application #
Study Section
National Center for Research Resources Initial Review Group (RIRG)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Stanford University
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Evangelou, Evangelos (see original citation for additional authors) (2018) Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits. Nat Genet 50:1412-1425
Doherty, Aiden; Smith-Byrne, Karl; Ferreira, Teresa et al. (2018) GWAS identifies 14 loci for device-measured physical activity and sleep duration. Nat Commun 9:5257
Askie, Lisa M; Darlow, Brian A; Finer, Neil et al. (2018) Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration. JAMA 319:2190-2201
Frayling, Timothy M; Beaumont, Robin N; Jones, Samuel E et al. (2018) A Common Allele in FGF21 Associated with Sugar Intake Is Associated with Body Shape, Lower Total Body-Fat Percentage, and Higher Blood Pressure. Cell Rep 23:327-336
Latva-Rasku, Aino; Honka, Miikka-Juhani; Stan?áková, Alena et al. (2018) A Partial Loss-of-Function Variant in AKT2 Is Associated With Reduced Insulin-Mediated Glucose Uptake in Multiple Insulin-Sensitive Tissues: A Genotype-Based Callback Positron Emission Tomography Study. Diabetes 67:334-342
Srinivasan, Lakshmi; Page, Grier; Kirpalani, Haresh et al. (2017) Genome-wide association study of sepsis in extremely premature infants. Arch Dis Child Fetal Neonatal Ed 102:F439-F445
Di Fiore, Juliann M; Martin, Richard J; Li, Hong et al. (2017) Patterns of Oxygenation, Mortality, and Growth Status in the Surfactant Positive Pressure and Oxygen Trial Cohort. J Pediatr 186:49-56.e1
Denson, Lee A; McDonald, Scott A; Das, Abhik et al. (2017) Early Elevation in Interleukin-6 is Associated with Reduced Growth in Extremely Low Birth Weight Infants. Am J Perinatol 34:240-247
Holmes, Michael V; Pulit, Sara L; Lindgren, Cecilia M (2017) Genetic and epigenetic studies of adiposity and cardiometabolic disease. Genome Med 9:82
Younge, Noelle; Goldstein, Ricki F; Bann, Carla M et al. (2017) Survival and Neurodevelopmental Outcomes among Periviable Infants. N Engl J Med 376:617-628

Showing the most recent 10 out of 589 publications